BDBM389793 2-Imidazo[4,5-b]pyridin-3-yl-1-((R)-2-methyl-4-{2-[2-(2,2,2-trifluoro-ethoxy)-pyrimidin-5-yl]-1,2,3,4-tetrahydro-isoquinolin-8-yl}-piperazin-1-yl)-ethanone::US9951063, 112

SMILES C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1cccc2CCN(Cc12)c1cnc(OCC(F)(F)F)nc1

InChI Key InChIKey=DRHLUYXJEFBSLO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 389793   

TargetC-X-C chemokine receptor type 3(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM389793(US9951063, 112 | 2-Imidazo[4,5-b]pyridin-3-yl-1-((...)
Affinity DataIC50: 2.98nMAssay Description:The bioactivity of compounds is tested in a fluorometric imaging plate reader (FLIPR: Molecular Devices) using engineered CHO-K1 cells expressing the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent